79 related articles for article (PubMed ID: 7590419)
1. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
[TBL] [Abstract][Full Text] [Related]
2. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas].
Mirouze J; Selam JL; Pham TC; Mendoza E
Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
Behme MT; Dupre J; Stiller CR
Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of cyclosporin in IDDM.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting remission in type I diabetes.
Pelkonen R; Aro A
Ann Clin Res; 1984; 16(2):94-7. PubMed ID: 6380392
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
[TBL] [Abstract][Full Text] [Related]
8. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
Mirouze J; Selam JL; Pham TC; Orsetti A
Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
[TBL] [Abstract][Full Text] [Related]
9. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
10. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
Krarup T; Madsbad S
Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
[TBL] [Abstract][Full Text] [Related]
11. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
Dupre J
Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
[TBL] [Abstract][Full Text] [Related]
13. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
16. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG
Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843
[TBL] [Abstract][Full Text] [Related]
18. [Importance of short-term administration of low doses of somatostatin analog in the development and remission of type 1 diabetes mellitus in adult patients].
Dvoráková H; Vondra K; Voborská M; Bendlová B; Kvapil M; Zamrazil V
Vnitr Lek; 1998 Apr; 44(4):227-31. PubMed ID: 9820108
[TBL] [Abstract][Full Text] [Related]
19. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
[TBL] [Abstract][Full Text] [Related]
20. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
